DZ2945A1 - Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation. - Google Patents

Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation.

Info

Publication number: DZ2945A1
Authority: DZ; Algeria
Prior art keywords: milbemycin; avermectin; preparation; formulations containing; antiparasitic formulations
Prior art date: 1998-11-19

Application number

DZ990245A

Other languages

English (en)

French (fr)

Inventor

Timothy Michael Lukas

Stephen Richard Wicks

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-19

Filing date

1999-11-17

Publication date

2004-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2945(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-17 Application filed by Pfizer filed Critical Pfizer

2004-03-15 Application granted granted Critical

2004-03-15 Publication of DZ2945A1 publication Critical patent/DZ2945A1/xx

Links

239000005660 Abamectin Substances 0.000 title 1
230000002141 anti-parasite Effects 0.000 title 1
239000003096 antiparasitic agent Substances 0.000 title 1
RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dentistry (AREA)
Organic Chemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Wood Science & Technology (AREA)
Environmental Sciences (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

DZ990245A 1998-11-19 1999-11-17 Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation. DZ2945A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9825402.2A GB9825402D0 (en)	1998-11-19	1998-11-19	Antiparasitic formulations

Publications (1)

Publication Number	Publication Date
DZ2945A1 true DZ2945A1 (fr)	2004-03-15

Family

ID=10842728

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990245A DZ2945A1 (fr)	1998-11-19	1999-11-17	Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation.

Country Status (43)

Country	Link
US (1)	US6797701B2 (sk)
EP (2)	EP1522219B1 (sk)
JP (1)	JP3507799B2 (sk)
KR (1)	KR100458406B1 (sk)
CN (1)	CN1147232C (sk)
AP (1)	AP1210A (sk)
AR (1)	AR023062A1 (sk)
AT (2)	ATE288201T1 (sk)
BG (1)	BG65440B1 (sk)
BR (1)	BR9915458B1 (sk)
CA (1)	CA2351730C (sk)
CO (1)	CO5150175A1 (sk)
CY (1)	CY1111955T1 (sk)
CZ (1)	CZ304345B6 (sk)
DE (2)	DE69923583T3 (sk)
DK (2)	DK1130966T4 (sk)
DZ (1)	DZ2945A1 (sk)
EA (1)	EA003959B1 (sk)
ES (2)	ES2344505T3 (sk)
GB (1)	GB9825402D0 (sk)
GT (1)	GT199900197A (sk)
HK (1)	HK1040593B (sk)
HR (1)	HRP20010368B1 (sk)
HU (1)	HU229493B1 (sk)
ID (1)	ID28698A (sk)
IL (3)	IL142104A0 (sk)
IS (1)	IS5907A (sk)
MA (1)	MA25029A1 (sk)
NO (1)	NO20012389D0 (sk)
NZ (2)	NZ510678A (sk)
OA (1)	OA11678A (sk)
PA (1)	PA8485501A1 (sk)
PE (1)	PE20001319A1 (sk)
PL (1)	PL204763B1 (sk)
PT (2)	PT1522219E (sk)
SI (2)	SI1522219T1 (sk)
SK (1)	SK287540B6 (sk)
TN (1)	TNSN99213A1 (sk)
TW (1)	TW526045B (sk)
UY (1)	UY25806A1 (sk)
WO (1)	WO2000030449A1 (sk)
YU (1)	YU23401A (sk)
ZA (1)	ZA997174B (sk)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6426333B1 (en)	1996-09-19	2002-07-30	Merial	Spot-on formulations for combating parasites
FR2753377B1 (fr)	1996-09-19	1999-09-24	Rhone Merieux	Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6998131B2 (en)	1996-09-19	2006-02-14	Merial Limited	Spot-on formulations for combating parasites
GB9825402D0 (en) *	1998-11-19	1999-01-13	Pfizer Ltd	Antiparasitic formulations
EP1215964A4 (en) *	1999-09-22	2002-11-05	Ashmont Holdings Ltd	POUR-ON COMPOSITION FOR SHEEP
AUPQ441699A0 (en) *	1999-12-02	2000-01-06	Eli Lilly And Company	Pour-on formulations
GB0108485D0 (en) *	2001-04-04	2001-05-23	Pfizer Ltd	Combination therapy
US20030064941A1 (en) *	2001-05-21	2003-04-03	Pfizer Inc.	Avermectin and praziquantel combination therapy
DK2347654T3 (en)	2001-09-17	2019-04-23	Elanco Us Inc	Formulation for the control of lice or ticks in cattle
KR100600402B1 (ko) *	2002-05-22	2006-07-14	주식회사 엘지생명과학	피부 도포용 이버멕틴 조성물 및 그 제조방법
US20040151759A1 (en) *	2002-08-16	2004-08-05	Douglas Cleverly	Non-animal product containing veterinary formulations
US20040037869A1 (en) *	2002-08-16	2004-02-26	Douglas Cleverly	Non-animal product containing veterinary formulations
US7666444B2 (en) *	2004-02-02	2010-02-23	Wyeth	Antiparasitic composition
DE102004053964A1 (de) *	2004-11-09	2006-05-11	Bayer Healthcare Ag	Mittel gegen Demodikose
IES20070395A2 (en) *	2006-12-05	2008-06-11	Michael Hilary Burke	A process for the preparation of a stable anhydrous anthelmintic formulation
DK2396006T3 (da) *	2009-02-16	2013-02-11	Ah Usa 42 Llc	Doramectinformulering med høj dosis
EP2416663A2 (en)	2009-03-18	2012-02-15	Martin Benedict George Donnelly	Parasiticidal formulation
UA108641C2 (uk)	2010-04-02	2015-05-25		Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
BRPI1002174A2 (pt) *	2010-06-17	2012-03-13	Rotam Agrochem International Company Ltd	Composição agroquímica, uso de um éter c2-c4 dialquileno glicol di-/mono-c1-c4 aquil, método para reduzir irritação ocular de formulações inseticidas líquidas, método de tratamento de praga em loco e uso da composição
KR20130044330A (ko) *	2010-07-30	2013-05-02	세바 상뜨 아니말르	사상충 체내 감염증을 조절하기 위한 조성물
EP2629770B1 (en) *	2010-10-20	2016-05-25	Galderma S.A.	Ivermectin for use in treating otitis externa
IT1403631B1 (it) *	2011-01-14	2013-10-31	Gsi Geosyntec Invest B V	Metodo e dispositivo per la posa e il tensionamento di una copertura impermeabile, per opere idrauliche in materiale sciolto.
BG1461U1 (bg) *	2011-03-18	2011-07-29	"Ендектовет" Еоод	Състави за противопаразитно лекарствено средство
BRPI1104180A2 (pt) *	2011-08-25	2013-08-13	Eurofarma Lab Ltda	composiÇÕes veterinÁrias pour on nço residuais, uso, kit, e mÉtodo de tratamento de parasitoses
AU2012324876A1 (en) *	2011-10-18	2014-05-01	Institut National De La Recherche Agronomique	Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
DK3351546T5 (da)	2011-12-02	2024-08-12	Boehringer Ingelheim Vetmedica Gmbh	Langtidsvirkende injicerbare moxidectinformuleringer
EP2833717B1 (en) *	2012-04-04	2021-02-17	Syngenta Participations AG	Pesticidal composition
AR094882A1 (es)	2013-02-26	2015-09-02	Zoetis Llc	Selamectina para el tratamiento de las infestaciones por piojos de mar, composición
EP2999339B1 (en) *	2013-05-20	2019-06-19	Zoetis Services LLC	Long-acting spiro-isoxazoline antiparasitic compositions
WO2016022066A1 (en)	2014-08-04	2016-02-11	Jerry Tan Eye Surgery Pte Ltd	Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
PL3595441T3 (pl)	2017-03-17	2023-12-04	Krka, D.D., Novo Mesto	Stabilna kompozycja weterynaryjna do stosowania miejscowego
AU2018372008B2 (en) *	2017-11-23	2024-03-28	Ceva Sante Animale	Composition containing moxidectin for treating parasites infestations
DK3723739T3 (da)	2017-12-15	2024-06-17	Tarsus Pharmaceuticals Inc	Isoxazolin-parasiticidformuleringer og deres anvendelse til behandling af blepharitis

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2753377B1 (fr) †	1996-09-19	1999-09-24	Rhone Merieux	Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
JPS4914624A (sk) *	1972-06-08	1974-02-08
US3839234A (en)	1973-01-26	1974-10-01	C Roscoe	Multi-purpose cleaning concentrate
SE434277B (sv) *	1976-04-19	1984-07-16	Merck & Co Inc	Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4206205A (en)	1977-10-03	1980-06-03	Merck & Co., Inc.	Monosaccharide and aglycone derivatives of C-076
GB2095107A (en) *	1981-03-24	1982-09-29	Janssen Pharmaceutica Nv	Tetramisole-or levamisole pour-on compositions
EP0170006B1 (en) *	1984-06-05	1992-07-08	American Cyanamid Company	Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
DE3584012D1 (de)	1985-01-22	1991-10-10	Saint Gobain Vitrage	Verfahren zur herstellung eines pulvers auf basis von indium-formiat zur herstellung einer duennen beschichtung auf einem substrat, insbesondere auf glas.
ES8800986A1 (es) *	1985-07-27	1987-12-01	Pfizer	Un procedimiento para la produccion de un nuevo derivado de avermectina
DE3545529A1 (de)	1985-12-20	1987-07-02	Autotyp Sa	Schneekette fuer fahrzeugraeder
LU86393A1 (fr)	1986-04-16	1987-12-07	Oreal	Composition anti-acneique stable a base d'erythromycine
EP0254583B1 (en) *	1986-07-24	1994-09-07	Beecham Group Plc	Parasiticidal milbemycin derivatives, a process for their production, and compositions containing the same
EP0284176B1 (en) *	1987-01-23	1993-08-25	Pfizer Inc.	Process for production of avermectins and cultures therefor
DE3727648A1 (de) †	1987-08-19	1989-03-02	Bayer Ag	Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
GB8721647D0 (en) *	1987-09-15	1987-10-21	Pfizer Ltd	Antiparasitic agents
GB8726730D0 (en) *	1987-11-14	1987-12-16	Pfizer Ltd	Antiparasitic agents
GB8804440D0 (en) *	1988-02-25	1988-03-23	Pfizer Ltd	Antiparasitic agents
GB8807280D0 (en) *	1988-03-26	1988-04-27	Pfizer Ltd	Antiparasitic agents
FR2630576B1 (fr) *	1988-04-26	1990-08-17	Realisations Nucleaires Et	Dispositif d'amelioration de la duree de vie et de la fiabilite d'un tube neutronique scelle a haut flux
GB8815967D0 (en)	1988-07-05	1988-08-10	Pfizer Ltd	Antiparasitic agents
US5015630A (en)	1989-01-19	1991-05-14	Merck & Co., Inc.	5-oxime avermectin derivatives
US4973468A (en) †	1989-03-22	1990-11-27	Cygnus Research Corporation	Skin permeation enhancer compositions
GB8917064D0 (en) *	1989-07-26	1989-09-13	Pfizer Ltd	Antiparasitic agent
DK0518989T3 (da) †	1990-03-05	1998-02-02	Mallinckrodt Veterinary Inc	Parasiticide præparater og fremgangsmåder til fremstilling og anvendelse deraf
GB9121028D0 (en)	1991-10-03	1991-11-13	Pfizer Ltd	Therapeutic agents
US5411737A (en) †	1991-10-15	1995-05-02	Merck & Co., Inc.	Slow release syneresing polymeric drug delivery device
GB9300883D0 (en) *	1993-01-18	1993-03-10	Pfizer Ltd	Antiparasitic agents
JP3966479B2 (ja) *	1993-04-16	2007-08-29	日本テキサス・インスツルメンツ株式会社	ゾルーゲル法による強誘電体膜の形成方法及びキャパシタの製造方法
BR9406594A (pt) *	1993-05-10	1996-01-02	Merck & Co Inc	Formulação tópica e processos para sua preparação e para o tratamento e prevenção de parasitas internos e externos de animais
TW327125B (en) *	1994-02-07	1998-02-21	Merck & Co Inc	Composition and method for protecting against pine exhausted
GB9402916D0 (en) *	1994-02-16	1994-04-06	Pfizer Ltd	Antiparasitic agents
DE19520275A1 (de) †	1995-06-02	1996-12-05	Bayer Ag	Endoparasitizide Mittel
CN1167683C (zh)	1996-01-30	2004-09-22	住化武田农药株式会社	芳基吡唑化合物、其制备方法、含其的农药组合物及其用途
DE19612644A1 (de) †	1996-03-29	1997-10-02	Bayer Ag	Oxadiazin-Derivate
GB9825402D0 (en) *	1998-11-19	1999-01-13	Pfizer Ltd	Antiparasitic formulations
FI107528B (fi)	1998-12-23	2001-08-31	Kemira Chemicals Oy	Menetelmä muurahaishapon valmistamiseksi

1998
- 1998-11-19 GB GBGB9825402.2A patent/GB9825402D0/en not_active Ceased
1999
- 1999-10-20 PL PL348638A patent/PL204763B1/pl unknown
- 1999-10-20 CN CNB998134554A patent/CN1147232C/zh not_active Expired - Lifetime
- 1999-10-20 PT PT05000644T patent/PT1522219E/pt unknown
- 1999-10-20 ES ES05000644T patent/ES2344505T3/es not_active Expired - Lifetime
- 1999-10-20 AT AT99972494T patent/ATE288201T1/de active
- 1999-10-20 DE DE69923583T patent/DE69923583T3/de not_active Expired - Lifetime
- 1999-10-20 SI SI9931046T patent/SI1522219T1/sl unknown
- 1999-10-20 DK DK99972494T patent/DK1130966T4/da active
- 1999-10-20 JP JP2000583347A patent/JP3507799B2/ja not_active Expired - Lifetime
- 1999-10-20 PT PT99972494T patent/PT1130966E/pt unknown
- 1999-10-20 SI SI9930759T patent/SI1130966T2/sl unknown
- 1999-10-20 AT AT05000644T patent/ATE469550T1/de active
- 1999-10-20 HK HK02102583.7A patent/HK1040593B/zh unknown
- 1999-10-20 NZ NZ510678A patent/NZ510678A/en not_active IP Right Cessation
- 1999-10-20 OA OA1200100119A patent/OA11678A/en unknown
- 1999-10-20 DK DK05000644.4T patent/DK1522219T3/da active
- 1999-10-20 SK SK662-2001A patent/SK287540B6/sk not_active IP Right Cessation
- 1999-10-20 CA CA002351730A patent/CA2351730C/en not_active Expired - Lifetime
- 1999-10-20 EP EP05000644A patent/EP1522219B1/en not_active Revoked
- 1999-10-20 CZ CZ2001-1734A patent/CZ304345B6/cs not_active IP Right Cessation
- 1999-10-20 ID IDW00200101096A patent/ID28698A/id unknown
- 1999-10-20 DE DE69942465T patent/DE69942465D1/de not_active Expired - Lifetime
- 1999-10-20 KR KR10-2001-7006309A patent/KR100458406B1/ko not_active Expired - Lifetime
- 1999-10-20 IL IL14210499A patent/IL142104A0/xx active IP Right Grant
- 1999-10-20 NZ NZ537110A patent/NZ537110A/en not_active IP Right Cessation
- 1999-10-20 YU YU23401A patent/YU23401A/sh unknown
- 1999-10-20 EA EA200100458A patent/EA003959B1/ru not_active IP Right Cessation
- 1999-10-20 HR HR20010368A patent/HRP20010368B1/xx not_active IP Right Cessation
- 1999-10-20 ES ES99972494T patent/ES2237213T3/es not_active Expired - Lifetime
- 1999-10-20 EP EP99972494A patent/EP1130966B2/en not_active Expired - Lifetime
- 1999-10-20 HU HU0104235A patent/HU229493B1/hu unknown
- 1999-10-20 BR BRPI9915458-7A patent/BR9915458B1/pt not_active IP Right Cessation
- 1999-10-20 WO PCT/IB1999/001715 patent/WO2000030449A1/en not_active Ceased
- 1999-10-26 TW TW088118505A patent/TW526045B/zh not_active IP Right Cessation
- 1999-11-16 PA PA19998485501A patent/PA8485501A1/es unknown
- 1999-11-17 AR ARP990105840A patent/AR023062A1/es active IP Right Grant
- 1999-11-17 DZ DZ990245A patent/DZ2945A1/xx active
- 1999-11-17 MA MA25851A patent/MA25029A1/fr unknown
- 1999-11-17 GT GT199900197A patent/GT199900197A/es unknown
- 1999-11-17 TN TNTNSN99213A patent/TNSN99213A1/fr unknown
- 1999-11-17 PE PE1999001163A patent/PE20001319A1/es not_active Application Discontinuation
- 1999-11-17 UY UY25806A patent/UY25806A1/es unknown
- 1999-11-18 CO CO99072702A patent/CO5150175A1/es unknown
- 1999-11-18 AP APAP/P/1999/001697A patent/AP1210A/en active
- 1999-11-18 ZA ZA9907174A patent/ZA997174B/xx unknown
2001
- 2001-03-19 IL IL142104A patent/IL142104A/en not_active IP Right Cessation
- 2001-03-23 IS IS5907A patent/IS5907A/is unknown
- 2001-05-15 NO NO20012389A patent/NO20012389D0/no not_active Application Discontinuation
- 2001-06-14 BG BG105601A patent/BG65440B1/bg unknown
- 2001-10-16 US US09/978,936 patent/US6797701B2/en not_active Expired - Lifetime
2006
- 2006-02-06 IL IL173567A patent/IL173567A0/en unknown
2010
- 2010-07-05 CY CY20101100619T patent/CY1111955T1/el unknown

Also Published As

Publication number	Publication date
NZ537110A (en)	2006-04-28
AR023062A1 (es)	2002-09-04
AP9901697A0 (en)	1999-12-31
BG65440B1 (bg)	2008-08-29
AP1210A (en)	2003-09-30
PE20001319A1 (es)	2000-12-02
EP1130966A1 (en)	2001-09-12
DE69942465D1 (de)	2010-07-15
PT1522219E (pt)	2010-07-19
IL142104A0 (en)	2002-03-10
SI1130966T1 (en)	2005-06-30
CN1326318A (zh)	2001-12-12
TW526045B (en)	2003-04-01
GT199900197A (es)	2001-05-10
DK1522219T3 (da)	2010-08-16
KR100458406B1 (ko)	2004-11-26
NZ510678A (en)	2003-08-29
EA003959B1 (ru)	2003-10-30
HUP0104235A2 (hu)	2002-03-28
JP2002530302A (ja)	2002-09-17
DE69923583T3 (de)	2009-12-24
UY25806A1 (es)	2001-08-27
BG105601A (en)	2002-01-31
CZ20011734A3 (cs)	2001-12-12
PA8485501A1 (es)	2000-09-29
SI1130966T2 (sl)	2009-08-31
ATE288201T1 (de)	2005-02-15
IL142104A (en)	2006-06-11
AU5995999A (en)	2000-06-13
EP1130966B1 (en)	2005-02-02
CO5150175A1 (es)	2002-04-29
HRP20010368A2 (en)	2002-06-30
CY1111955T1 (el)	2015-11-04
HK1040593B (zh)	2004-10-08
DK1130966T3 (da)	2005-05-09
YU23401A (sh)	2005-06-10
ES2237213T3 (es)	2009-08-19
ID28698A (id)	2001-06-28
EA200100458A1 (ru)	2001-10-22
ATE469550T1 (de)	2010-06-15
WO2000030449A1 (en)	2000-06-02
SK287540B6 (sk)	2011-01-04
ES2344505T3 (es)	2010-08-30
DE69923583D1 (de)	2005-03-10
HU229493B1 (en)	2014-01-28
GB9825402D0 (en)	1999-01-13
CN1147232C (zh)	2004-04-28
EP1130966B2 (en)	2009-05-27
JP3507799B2 (ja)	2004-03-15
NO20012389L (no)	2001-05-15
SK6622001A3 (en)	2001-12-03
CZ304345B6 (cs)	2014-03-19
HK1040593A1 (en)	2002-06-21
CA2351730C (en)	2006-12-05
CA2351730A1 (en)	2000-06-02
DE69923583T2 (de)	2006-01-12
EP1522219B1 (en)	2010-06-02
EP1522219A1 (en)	2005-04-13
AU757892B2 (en)	2003-03-13
HUP0104235A3 (en)	2004-03-01
US20020028780A1 (en)	2002-03-07
DK1130966T4 (da)	2009-07-20
US6797701B2 (en)	2004-09-28
IS5907A (is)	2001-03-23
BR9915458B1 (pt)	2011-04-19
MA25029A1 (fr)	2000-07-01
TNSN99213A1 (fr)	2005-11-10
PT1130966E (pt)	2005-04-29
HRP20010368B1 (en)	2004-06-30
PL348638A1 (en)	2002-06-03
BR9915458A (pt)	2001-07-17
IL173567A0 (en)	2006-07-05
PL204763B1 (pl)	2010-02-26
NO20012389D0 (no)	2001-05-15
KR20010080505A (ko)	2001-08-22
SI1522219T1 (sl)	2010-09-30
OA11678A (en)	2005-01-12
ZA997174B (en)	2001-05-18

Publication	Publication Date	Title
DZ2945A1 (fr)	2004-03-15	Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation.
DZ2962A1 (fr)	2004-03-15	Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2889A1 (fr)	2003-12-15	4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26551A1 (fr)	2004-12-20	Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2172A1 (fr)	2002-12-01	Dérivés de triazole utiles on thérapeutique, procédé pour leur préparation et compositions les contenant.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1878A1 (fr)	2002-02-17	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
MA24529A1 (fr)	1998-12-31	Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
FR2718450B1 (fr)	1997-01-10	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DZ2753A1 (fr)	2005-09-15	Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant.
DZ3045A1 (fr)	2004-03-27	Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2217A1 (fr)	2002-12-03	Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant.
MA26414A1 (fr)	2004-12-20	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
DZ2944A1 (fr)	2004-03-15	Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.
MA24484A1 (fr)	1998-10-01	Atropisomeres de 3-aryl-4(3h)-quinazolinones, procede pour leur preparation et compositions les contenant .
DZ2887A1 (fr)	2003-12-15	Dérivés d'azétidine, leur préparation et les médicaments les contenant.
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2866A1 (fr)	2003-12-01	1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3000A1 (fr)	2004-03-27	Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant.
MA26514A1 (fr)	2004-12-20	Agonistes de prostaglandines, procede pour leur preparation et compositions pharmaceutiques les contenant.